+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Head And Neck Cancer Drug"

Europe Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 86 Pages
  • Europe
From
Asia Pacific Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 86 Pages
  • Asia Pacific
From
North America Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Head And Neck Cancer Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy Type (Immunotherapy, Chemotherapy, and Targeted Therapy), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 77 Pages
  • North America
From
US Head & Neck Cancers Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Head & Neck Cancers Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Head & Neck Cancers Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Head & Neck Cancers Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Head & Neck Cancer Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Head & Neck Cancer Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Global
From
Head And Neck Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 3419 Pages
  • Global
From
Head and Neck Cancer Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Head and Neck Cancer Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 77 Pages
  • Global
From
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Care of Head and Neck Cancer Patients for Dental Hygienists and Dental Therapists. Edition No. 1 - Product Thumbnail Image

Care of Head and Neck Cancer Patients for Dental Hygienists and Dental Therapists. Edition No. 1

  • Book
  • January 2023
  • 304 Pages
Loading Indicator

The Head and Neck Cancer Drug market is a subset of the larger Oncology Drugs market. It includes drugs used to treat cancers of the head and neck, such as squamous cell carcinoma, salivary gland cancer, and nasopharyngeal cancer. These drugs are typically used in combination with radiation therapy and/or surgery to treat the cancer. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and monoclonal antibodies. The Head and Neck Cancer Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Roche. Other companies include Novartis, Eli Lilly, and GlaxoSmithKline. Show Less Read more